On Location ASH Annual Meeting
Salvage Regimen of Pomalidomide, Cyclophosphamide, and Dexamethasone
Has High Response Rates in Lenalidomide-Refractory Myeloma Patients
Eighty-five percent of patients with
relapsed/refractory multiple myeloma
(MM) achieved a partial remission
(PR) or better (primary endpoint)
when cyclophosphamide was a